title: Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain.
abstract: Ziconotide is a conopeptide intrathecal (IT) analgesic which is approved by the US Food and Drug Administration (FDA) for the management of severe chronic pain. It is a synthetic equivalent of a naturally occurring conopeptide found in the venom of the fish-eating marine cone snail and provides analgesia via binding to N-type voltage-sensitive calcium channels in the spinal cord. As ziconotide is a peptide, it is expected to be completely degraded by endopeptidases and exopeptidases (Phase I hydrolytic enzymes) widely located throughout the body, and not by other Phase I biotransformation processes (including the cytochrome P450 system) or by Phase II conjugation reactions. Thus, IT administration, low plasma ziconotide concentrations, and metabolism by ubiquitous peptidases make metabolic interactions of other drugs with ziconotide unlikely. Side effects of ziconotide which tend to occur more commonly at higher doses may include: nausea, vomiting, confusion, postural hypotension, abnormal gait, urinary retention, nystagmus/amblyopia, drowsiness/somnolence (reduced level of consciousness), dizziness or lightheadedness, weakness, visual problems (eg, double vision), elevation of serum creatine kinase, or vestibular side effects. Initially, when ziconotide was first administered to human subjects, titration schedules were overly aggressive and led to an abundance of adverse effects. Subsequently, clinicians have gained appreciation for ziconotide's relatively narrow therapeutic window. With appropriate usage multiple studies have shown ziconotide to be a safe and effective intrathecal analgesic alone or in combination with other intrathecal analgesics.
authors.affiliation: Albany Medical College, Department of Anesthesiology, Albany, New York, USA.
authors.forename: Howard S
authors.initials: HS
authors.lastname: Smith
authors.forename: Timothy R
authors.initials: TR
authors.lastname: Deer
references.citation: Anesth Analg. 2008 Feb;106(2):628-37, table of contents
references.pmid: 18227325
references.citation: Annu Rev Biochem. 1994;63:823-67
references.pmid: 7979255
references.citation: J Theor Biol. 2006 Nov 21;243(2):252-60
references.pmid: 16890961
references.citation: J Pain Symptom Manage. 2004 Jun;27(6):540-63
references.pmid: 15165652
references.citation: Rev Neurol. 2007 Dec 1-15;45(11):665-9
references.pmid: 18050098
references.citation: Pain Med. 2008 Apr;9(3):271-81
references.pmid: 18366507
references.citation: Annu Rev Pharmacol Toxicol. 1995;35:707-34
references.pmid: 7598513
references.citation: Eur J Phys Rehabil Med. 2009 Mar;45(1):61-7
references.pmid: 19156022
references.citation: J Pain Symptom Manage. 2004 Sep;28(3):268-72
references.pmid: 15336339
references.citation: CNS Drugs. 2006;20(4):331-8; discussion 339-41
references.pmid: 16599651
references.citation: Pain. 2000 Feb;84(2-3):271-81
references.pmid: 10666532
references.citation: Mol Cell Neurosci. 1994 Jun;5(3):219-28
references.pmid: 8087420
references.citation: Neuromodulation. 2005 Jul;8(3):153-4
references.pmid: 22151483
references.citation: J Neurosci. 1987 Aug;7(8):2390-6
references.pmid: 3112325
references.citation: J Biol Chem. 2006 Oct 20;281(42):31173-7
references.pmid: 16905531
references.citation: Neuromodulation. 2007 Oct;10 Suppl 1:6-11
references.pmid: 22150946
references.citation: Expert Rev Neurother. 2006 Oct;6(10):1423-8
references.pmid: 17078783
references.citation: J Pain Symptom Manage. 2009 Mar;37(3):363-72
references.pmid: 18715748
references.citation: Peptides. 2000 Apr;21(4):491-501
references.pmid: 10822104
references.citation: Curr Med Chem. 2004 Dec;11(23):3029-40
references.pmid: 15578997
references.citation: Neuromodulation. 2007 Oct;10 Suppl 1:12-7
references.pmid: 22150947
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2002 Sep;366(3):270-5
references.pmid: 12172710
references.citation: Biochemistry. 1987 Apr 21;26(8):2086-90
references.pmid: 2441741
references.citation: Anesthesiology. 2003 Jul;99(1):174-87
references.pmid: 12826858
references.citation: Brain Res. 1994 Aug 8;653(1-2):258-66
references.pmid: 7982059
references.citation: Drug Saf. 2007;30(2):93-105
references.pmid: 17253876
references.citation: J Biol Chem. 2007 Dec 21;282(51):36905-13
references.pmid: 17962189
references.citation: JAMA. 2004 Jan 7;291(1):63-70
references.pmid: 14709577
references.citation: Neuromodulation. 2005 Oct;8(4):257-63
references.pmid: 22151554
references.citation: J Clin Pharmacol. 2003 Jun;43(6):624-36
references.pmid: 12817525
references.citation: Neuromodulation. 2007 Oct;10(4):300-28
references.pmid: 22150890
references.citation: Pain Med. 2008 Apr;9(3):282-90
references.pmid: 18366508
references.citation: Physiol Rev. 2004 Jan;84(1):41-68
references.pmid: 14715910
references.citation: Neuroreport. 1994 May 9;5(9):1121-4
references.pmid: 8080970
references.citation: Biochem Biophys Res Commun. 1995 Jan 17;206(2):449-54
references.pmid: 7826361
references.citation: Toxicon. 1998 Nov;36(11):1651-8
references.pmid: 9792182
references.citation: Biochem Biophys Res Commun. 2007 Mar 9;354(2):548-51
references.pmid: 17239817
references.citation: Int J Pept Protein Res. 1995 Sep-Oct;46(3-4):320-5
references.pmid: 8537186
references.citation: J Pain Symptom Manage. 2006 May;31(5):393-406
references.pmid: 16716870
references.citation: Biochemistry. 2000 Apr 11;39(14):3908-19
references.pmid: 10747778
references.citation: Neuromodulation. 2007 Oct;10 Suppl 1:1-5
references.pmid: 22150945
references.citation: Neuromodulation. 2006 Apr;9(2):75-86
references.pmid: 22151630
references.citation: Science. 1990 Jul 20;249(4966):257-63
references.pmid: 2165278
references.citation: Brain Nerve. 2008 May;60(5):509-17
references.pmid: 18516973
references.citation: Biochemistry. 1998 Jul 7;37(27):9851-61
references.pmid: 9657699
references.citation: Biochemistry. 2009 Feb 17;48(6):1210-9
references.pmid: 19170536
references.citation: Pain. 1995 Jan;60(1):83-90
references.pmid: 7715945
references.citation: Pain. 2000 Feb;84(2-3):151-8
references.pmid: 10666519
references.citation: J Pain Symptom Manage. 2000 Aug;20(2):S37-43
references.pmid: 10989256
references.citation: Pharmacotherapy. 2006 Mar;26(3):395-402
references.pmid: 16503720
references.citation: Pain Physician. 2008 Mar;11(2 Suppl):S89-S104
references.pmid: 18443642
references.citation: Int J Toxicol. 2007 Sep-Oct;26(5):411-21
references.pmid: 17963128
references.citation: J Pharmacol Exp Ther. 1996 Dec;279(3):1243-9
references.pmid: 8968347
references.citation: J Pain Symptom Manage. 2006 Dec;32(6):509-11
references.pmid: 17157748